United States Regenerative Medicines Market Report 2019

Table of Contents

United States Regenerative Medicines Market Report 2017
1 Regenerative Medicines Overview
1.1 Product Overview and Scope of Regenerative Medicines
1.2 Classification of Regenerative Medicines by Product Category
1.2.1 United States Regenerative Medicines Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Regenerative Medicines Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Cell Therapy
1.2.4 Gene Therapy
1.2.5 Tissue Engineering
1.2.6 Small Molecules & Biologics
1.3 United States Regenerative Medicines Market by Application/End Users
1.3.1 United States Regenerative Medicines Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Cardiovascular
1.3.3 Oncology
1.3.4 Dermatology
1.3.5 Musculoskeletal
1.3.6 Wound Healing
1.3.7 Ophthalmology
1.3.8 Neurology
1.3.9 Others
1.4 United States Regenerative Medicines Market by Region
1.4.1 United States Regenerative Medicines Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Regenerative Medicines Status and Prospect (2012-2022)
1.4.3 Southwest Regenerative Medicines Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Regenerative Medicines Status and Prospect (2012-2022)
1.4.5 New England Regenerative Medicines Status and Prospect (2012-2022)
1.4.6 The South Regenerative Medicines Status and Prospect (2012-2022)
1.4.7 The Midwest Regenerative Medicines Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Regenerative Medicines (2012-2022)
1.5.1 United States Regenerative Medicines Sales and Growth Rate (2012-2022)
1.5.2 United States Regenerative Medicines Revenue and Growth Rate (2012-2022)

2 United States Regenerative Medicines Market Competition by Players/Suppliers
2.1 United States Regenerative Medicines Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Regenerative Medicines Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Regenerative Medicines Average Price by Players/Suppliers (2012-2017)
2.4 United States Regenerative Medicines Market Competitive Situation and Trends
2.4.1 United States Regenerative Medicines Market Concentration Rate
2.4.2 United States Regenerative Medicines Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Regenerative Medicines Manufacturing Base Distribution, Sales Area, Product Type

3 United States Regenerative Medicines Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Regenerative Medicines Sales and Market Share by Region (2012-2017)
3.2 United States Regenerative Medicines Revenue and Market Share by Region (2012-2017)
3.3 United States Regenerative Medicines Price by Region (2012-2017)

4 United States Regenerative Medicines Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Regenerative Medicines Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Regenerative Medicines Revenue and Market Share by Type (2012-2017)
4.3 United States Regenerative Medicines Price by Type (2012-2017)
4.4 United States Regenerative Medicines Sales Growth Rate by Type (2012-2017)

5 United States Regenerative Medicines Sales (Volume) by Application (2012-2017)
5.1 United States Regenerative Medicines Sales and Market Share by Application (2012-2017)
5.2 United States Regenerative Medicines Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Regenerative Medicines Players/Suppliers Profiles and Sales Data
6.1 Stryker Corporation
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Regenerative Medicines Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Stryker Corporation Regenerative Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Zimmer Biomet Holdings
6.2.2 Regenerative Medicines Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Zimmer Biomet Holdings Regenerative Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Medtronic
6.3.2 Regenerative Medicines Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Medtronic Regenerative Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Baxter International
6.4.2 Regenerative Medicines Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Baxter International Regenerative Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 DePuy Synthes
6.5.2 Regenerative Medicines Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 DePuy Synthes Regenerative Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Organogenesis
6.6.2 Regenerative Medicines Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Organogenesis Regenerative Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Integra Lifesciences Holdings Corporation
6.7.2 Regenerative Medicines Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Integra Lifesciences Holdings Corporation Regenerative Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Acelity Holdings
6.8.2 Regenerative Medicines Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Acelity Holdings Regenerative Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Ocata Therapeutics
6.9.2 Regenerative Medicines Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Ocata Therapeutics Regenerative Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 CryoLife
6.10.2 Regenerative Medicines Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 CryoLife Regenerative Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview

7 Regenerative Medicines Manufacturing Cost Analysis
7.1 Regenerative Medicines Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Regenerative Medicines

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Regenerative Medicines Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Regenerative Medicines Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Regenerative Medicines Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Regenerative Medicines Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Regenerative Medicines Sales Volume Forecast by Type (2017-2022)
11.3 United States Regenerative Medicines Sales Volume Forecast by Application (2017-2022)
11.4 United States Regenerative Medicines Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer



List of Tables and Figures

Figure Product Picture of Regenerative Medicines
Figure United States Regenerative Medicines Market Size (K Units) by Type (2012-2022)
Figure United States Regenerative Medicines Sales Volume Market Share by Type (Product Category) in 2016
Figure Cell Therapy Product Picture
Figure Gene Therapy Product Picture
Figure Tissue Engineering Product Picture
Figure Small Molecules & Biologics Product Picture
Figure United States Regenerative Medicines Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Regenerative Medicines by Application in 2016
Figure Cardiovascular Examples
Table Key Downstream Customer in Cardiovascular
Figure Oncology Examples
Table Key Downstream Customer in Oncology
Figure Dermatology Examples
Table Key Downstream Customer in Dermatology
Figure Musculoskeletal Examples
Table Key Downstream Customer in Musculoskeletal
Figure Wound Healing Examples
Table Key Downstream Customer in Wound Healing
Figure Ophthalmology Examples
Table Key Downstream Customer in Ophthalmology
Figure Neurology Examples
Table Key Downstream Customer in Neurology
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Regenerative Medicines Market Size (Million USD) by Region (2012-2022)
Figure The West Regenerative Medicines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Regenerative Medicines Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Regenerative Medicines Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Regenerative Medicines Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Regenerative Medicines Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Regenerative Medicines Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Regenerative Medicines Sales (K Units) and Growth Rate (2012-2022)
Figure United States Regenerative Medicines Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Regenerative Medicines Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Regenerative Medicines Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Regenerative Medicines Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Regenerative Medicines Sales Share by Players/Suppliers
Figure 2017 United States Regenerative Medicines Sales Share by Players/Suppliers
Figure United States Regenerative Medicines Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Regenerative Medicines Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Regenerative Medicines Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Regenerative Medicines Revenue Share by Players/Suppliers
Figure 2017 United States Regenerative Medicines Revenue Share by Players/Suppliers
Table United States Market Regenerative Medicines Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Regenerative Medicines Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Regenerative Medicines Market Share of Top 3 Players/Suppliers
Figure United States Regenerative Medicines Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Regenerative Medicines Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Regenerative Medicines Product Category
Table United States Regenerative Medicines Sales (K Units) by Region (2012-2017)
Table United States Regenerative Medicines Sales Share by Region (2012-2017)
Figure United States Regenerative Medicines Sales Share by Region (2012-2017)
Figure United States Regenerative Medicines Sales Market Share by Region in 2016
Table United States Regenerative Medicines Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Regenerative Medicines Revenue Share by Region (2012-2017)
Figure United States Regenerative Medicines Revenue Market Share by Region (2012-2017)
Figure United States Regenerative Medicines Revenue Market Share by Region in 2016
Table United States Regenerative Medicines Price (USD/Unit) by Region (2012-2017)
Table United States Regenerative Medicines Sales (K Units) by Type (2012-2017)
Table United States Regenerative Medicines Sales Share by Type (2012-2017)
Figure United States Regenerative Medicines Sales Share by Type (2012-2017)
Figure United States Regenerative Medicines Sales Market Share by Type in 2016
Table United States Regenerative Medicines Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Regenerative Medicines Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Regenerative Medicines by Type (2012-2017)
Figure Revenue Market Share of Regenerative Medicines by Type in 2016
Table United States Regenerative Medicines Price (USD/Unit) by Types (2012-2017)
Figure United States Regenerative Medicines Sales Growth Rate by Type (2012-2017)
Table United States Regenerative Medicines Sales (K Units) by Application (2012-2017)
Table United States Regenerative Medicines Sales Market Share by Application (2012-2017)
Figure United States Regenerative Medicines Sales Market Share by Application (2012-2017)
Figure United States Regenerative Medicines Sales Market Share by Application in 2016
Table United States Regenerative Medicines Sales Growth Rate by Application (2012-2017)
Figure United States Regenerative Medicines Sales Growth Rate by Application (2012-2017)
Table Stryker Corporation Basic Information List
Table Stryker Corporation Regenerative Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Stryker Corporation Regenerative Medicines Sales Growth Rate (2012-2017)
Figure Stryker Corporation Regenerative Medicines Sales Market Share in United States (2012-2017)
Figure Stryker Corporation Regenerative Medicines Revenue Market Share in United States (2012-2017)
Table Zimmer Biomet Holdings Basic Information List
Table Zimmer Biomet Holdings Regenerative Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Zimmer Biomet Holdings Regenerative Medicines Sales Growth Rate (2012-2017)
Figure Zimmer Biomet Holdings Regenerative Medicines Sales Market Share in United States (2012-2017)
Figure Zimmer Biomet Holdings Regenerative Medicines Revenue Market Share in United States (2012-2017)
Table Medtronic Basic Information List
Table Medtronic Regenerative Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Medtronic Regenerative Medicines Sales Growth Rate (2012-2017)
Figure Medtronic Regenerative Medicines Sales Market Share in United States (2012-2017)
Figure Medtronic Regenerative Medicines Revenue Market Share in United States (2012-2017)
Table Baxter International Basic Information List
Table Baxter International Regenerative Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Baxter International Regenerative Medicines Sales Growth Rate (2012-2017)
Figure Baxter International Regenerative Medicines Sales Market Share in United States (2012-2017)
Figure Baxter International Regenerative Medicines Revenue Market Share in United States (2012-2017)
Table DePuy Synthes Basic Information List
Table DePuy Synthes Regenerative Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure DePuy Synthes Regenerative Medicines Sales Growth Rate (2012-2017)
Figure DePuy Synthes Regenerative Medicines Sales Market Share in United States (2012-2017)
Figure DePuy Synthes Regenerative Medicines Revenue Market Share in United States (2012-2017)
Table Organogenesis Basic Information List
Table Organogenesis Regenerative Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Organogenesis Regenerative Medicines Sales Growth Rate (2012-2017)
Figure Organogenesis Regenerative Medicines Sales Market Share in United States (2012-2017)
Figure Organogenesis Regenerative Medicines Revenue Market Share in United States (2012-2017)
Table Integra Lifesciences Holdings Corporation Basic Information List
Table Integra Lifesciences Holdings Corporation Regenerative Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Integra Lifesciences Holdings Corporation Regenerative Medicines Sales Growth Rate (2012-2017)
Figure Integra Lifesciences Holdings Corporation Regenerative Medicines Sales Market Share in United States (2012-2017)
Figure Integra Lifesciences Holdings Corporation Regenerative Medicines Revenue Market Share in United States (2012-2017)
Table Acelity Holdings Basic Information List
Table Acelity Holdings Regenerative Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Acelity Holdings Regenerative Medicines Sales Growth Rate (2012-2017)
Figure Acelity Holdings Regenerative Medicines Sales Market Share in United States (2012-2017)
Figure Acelity Holdings Regenerative Medicines Revenue Market Share in United States (2012-2017)
Table Ocata Therapeutics Basic Information List
Table Ocata Therapeutics Regenerative Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Ocata Therapeutics Regenerative Medicines Sales Growth Rate (2012-2017)
Figure Ocata Therapeutics Regenerative Medicines Sales Market Share in United States (2012-2017)
Figure Ocata Therapeutics Regenerative Medicines Revenue Market Share in United States (2012-2017)
Table CryoLife Basic Information List
Table CryoLife Regenerative Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure CryoLife Regenerative Medicines Sales Growth Rate (2012-2017)
Figure CryoLife Regenerative Medicines Sales Market Share in United States (2012-2017)
Figure CryoLife Regenerative Medicines Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Regenerative Medicines
Figure Manufacturing Process Analysis of Regenerative Medicines
Figure Regenerative Medicines Industrial Chain Analysis
Table Raw Materials Sources of Regenerative Medicines Major Players/Suppliers in 2016
Table Major Buyers of Regenerative Medicines
Table Distributors/Traders List
Figure United States Regenerative Medicines Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Regenerative Medicines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Regenerative Medicines Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Regenerative Medicines Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Regenerative Medicines Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Regenerative Medicines Sales Volume (K Units) Forecast by Type in 2022
Table United States Regenerative Medicines Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Regenerative Medicines Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Regenerative Medicines Sales Volume (K Units) Forecast by Application in 2022
Table United States Regenerative Medicines Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Regenerative Medicines Sales Volume Share Forecast by Region (2017-2022)
Figure United States Regenerative Medicines Sales Volume Share Forecast by Region (2017-2022)
Figure United States Regenerative Medicines Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources